Online Appendix for Selection Effects and Covid-19 Mortality Risk after Pfizer vs. Moderna Vaccination: Evidence from Linked Mortality and Vaccination Records
Vaccines 2023, 11(5), 971
30 Pages Posted: 20 Jan 2023 Last revised: 20 May 2023
Date Written: January 10, 2023
This Appendix provides additional data source and methods details and additional results for Atanasov et. al, Relative Effectiveness of COVID-19 Vaccines from Moderna and Pfizer: Evidence from Linked Mortality and Vaccination Records (working paper 2023).
The underlying paper is available at http://ssrn.com/abstract=4321773
Funding Information: This project was funded by the National Institutes of Health, award 3 UL1 TR001436-06S1.
Declaration of Interests: The authors have no competing interests.
Ethics Approval Statement: Approved by the Medical College of Wisconsin Human Research Review Board.
Keywords: COVID-19 mortality rates; COVID-19 Excess Mortality Percentage; vaccine effectiveness, Moderna vaccine, mRNA1273, Pfizer vaccine, Pfizer-BioNTech vaccine, BNT162b2.
Suggested Citation: Suggested Citation